|
Biomechanical effects of CARLEN vs. MitraClip to be presented at the World Congress of Biomechanics 2022
CARLEN is a more physiologically apt repair than current TEER technologies. Come see us present our data on this topic and why it matters in the long run for patients
|
|
|
Efficacy data on CARLEN's ability to repair FMR in a variety of etiologies to be presented at the 2022 annual meeting of the Heart Valve Society
Come check us out at the Mitral Valve 2 session - modern concepts in functional mitral regurgitation on Friday, March 4, 2022
|
|
CARLEN technology was presented at the Scientific Sessions of the American Heart AssociationNov 2021: The CARLEN technology to be presented as a moderated presentation at the 2021 Scientific Sessions of the American Heart Association to be held in Nov 2021
|
|
CARLEN technology licensed from Emory UniversityJan 2021: Nyra Medical acquires exclusive, world wide rights to the cardiac leaflet enhancer technology portfolio of patents from Emory University
|
|
Nyra Medical selected as a finalist at the TCT Shark TankSept 2019: Nyra Medical was selected as a finalist for the TCT shark tank, that showcases the up and coming novel technologies in interventional cardiology.
|
|